Physician profile

John Frank Bennetts

Addiction Medicine (Family Medicine) · Monterey, CA

NPI 1477666345

$5,419.48

in general payments reported to CMS, 2019-2025

33 companies · none reported in 2025

See the full distribution for Addiction Medicine (Family Medicine)

Payments by year

General payments by program year, as reported to CMS.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Lilly USA, LLC $1,173.81 2019-2021
Abbvie INC. $789.43 2019-2022
Glaxosmithkline, LLC. $788.11 2019-2021
Sunovion Pharmaceuticals INC. $385.24 2019-2022
Mylan Specialty L.P. $302.53 2019-2022
Abbott Laboratories $273.13 2022
Allergan, INC. $256.34 2019-2020
Pfizer INC. $214.62 2019-2021
Boehringer Ingelheim Pharmaceuticals, INC. $159.76 2019-2022
Vertos Medical, INC. $128.84 2021
Amgen INC. $118.15 2019-2020
Redhill Biopharma INC. $95.06 2020-2021
Indivior INC. $90.44 2019-2021
Merck Sharp & Dohme LLC $85.72 2019-2022
Astrazeneca Pharmaceuticals LP $67.48 2020-2022
Show all 33 companies

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

John Frank Bennetts

$5,419.48

in general payments reported 2019-2025

Years
2019-2022
Top company
Lilly USA, LLC

https://glasscript.com/doctor/111959/john-frank-bennetts

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.